LISDEXAMFETAMINE IN THIS COUNTRY : A DETAILED OVERVIEW

Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug approved in Canada for treating Attention-Deficit/Hyperactivity Disorder in youngsters and adults . This functions as a prodrug, meaning it’s dormant until processed by the body, dispensing dextroamphetamine gradually over an extended dur